2022 Medicinal Chemistry Reviews, pages 447-471

THE RISE, FALL, AND FUTURE PROMISE OF IDO1 INHIBITORS FOR IMMUNO-ONCOLOGY

Emily C Cherney 1
DAVID K. WILLIAMS 1
Liping Zhang 1
Susheel J Nara 2
1
 
Bristol Myers Squibb, Lawrenceville, New Jersey, U.S.A.
2
 
Biocon BMS R&D Center, Bengaluru, India
Publication typeBook Chapter
Publication date2023-11-16
SJR
CiteScore
Impact factor
ISSN25759183, 25759175

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex
Found error?